Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05687253 · ClinicalTrials.gov registry record · Phase 2
Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery
A Phase 2 study, sponsored by Baudax Bio.
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT05687253: Completed Phase 2 study, sponsored by Baudax Bio.
NCT05687253 is a Phase 2 study that has completed, run by Baudax Bio. The registered enrollment target is 80 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05687253, a Phase 2 study, has completed, sponsored by Baudax Bio.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
Assessment of Intubation conditions following administration of neuromuscular blocking agents; BX1000 (investigational) or rocuronium (active control).
Primary Outcome
Assessment of Intubation Conditions (Poor, Good, Excellent) Following Administration of Neuromuscular Blocking agent
Interventions
- DRUG BX1000
- DRUG Rocuronium Bromide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-10-25 |
| Est. Completion | 2023-05-08 |
| Phase | Phase 2 |
What the finished NCT05687253 record still lists
NCT05687253 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (40% lower).
The record links to 0 conditions, and to 2 interventions - of which BX1000 is the first listed.
NCT05687253 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05687253 about?
NCT05687253 is a clinical study titled "Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery". Assessment of Intubation conditions following administration of neuromuscular blocking agents; BX1000 (investigational) or rocuronium (active control).
What is the current status of trial NCT05687253?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2022-10-25. Estimated completion is 2023-05-08.
What interventions are being tested in trial NCT05687253?
The interventions under investigation include: BX1000 (DRUG), Rocuronium Bromide (DRUG).
Who is sponsoring clinical trial NCT05687253?
This trial is sponsored by Baudax Bio, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05687253's enrollment target sits among peer trials
80 842nd of 2000 higher than 1,117 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI